搜索优化
Rewards
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 24 小时
时间不限
过去 1 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
STAT
8 小时
Amgen scores late-stage trial success for eczema and myasthenia gravis treatments, but ...
Amgen on Tuesday reported that a pair of antibody drugs it is developing as treatments for immune-mediated diseases succeeded ...
7 小时
on MSN
Amgen's muscular disorder drug meets main goal in late-stage study
Amgen said on Tuesday that its drug helped improve daily activities including chewing and swallowing in patients suffering ...
Verywell Health on MSN
11 小时
Leaky Gut Syndrome: What Is Known and Unknown?
There is no approved diagnosis or treatment method for it. People who discuss leaky gut think the gut lining has become more ...
1 小时
New Data Shows ZORYVE® (Roflumilast) Cream 0.15% Provided Consistent Improvement of Atopic ...
ZORYVE demonstrated consistent efficacy in disease clearance and reduction in itch for individuals with atopic dermatitis (AD) regardless of ...
Kashmir Observer
14 小时
Ozone Therapy: Revitalizing Health with Ancient Wisdom and Modern Science
Representational Photo By Dipak Kurmi In the quest for optimal health and wellness, balancing life’s demands with healing ...
inc42
12 小时
Ahammune Biosciences Raises $5 Mn To Speed Up Drug Development For Vitiligo
Biotech startup Ahammune Biosciences has raised $5 Mn (about INR 41 Cr) in its Series A round led by pi Ventures.
biopharma-reporter
16 小时
UCB and Biogen announce positive Phase 3 results for dapirolizumab pegol in systemic lupus ...
UCB and Biogen revealed that their Phase 3 study testing dapirolizumab pegol in people with systemic lupus erythematosus met ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈